Skip to main content
. 2021 Jan 6;16(1):e0244673. doi: 10.1371/journal.pone.0244673

Table 4. Chequerboard results of colistin in combination with aminoglycoside (amikacin, gentamicin and tobramycin) against colistin resistant K. pneumoniae isolates.

Isolates Antibiotics Combined MIC (μg/mL) FICI Fold reduction Outcome
1NT4Ng/1 COL 8 0.281 32 Synergy
AMI 4 4
COL 32 0.375 8 Synergy
GEN 32 4
COL 64 0.500 4 Synergy
TOB 8 4
1NT6Ng/1 COL 8 0.281 32 Synergy
AMI 4 4
COL 8 0.281 32 Synergy
GEN 32 4
COL 64 0.500 4 Synergy
TOB 8 4
1NT6Tu/1 COL 64 0.265 4 Synergy
AMI 0.12 64
COL 8 0.281 32 Synergy
GEN 64 4
COL ND ND ND ND
TOB ND
1NT6R COL 16 0.078 16 Synergy
AMI 0.25 64
COL 16 0.125 16 Synergy
GEN 8 16
COL 32 0.375 8 Synergy
TOB 16 4
1NT7R COL ND ND ND ND
AMI ND
COL 32 0.375 8 Synergy
GEN 32 4
COL ND ND ND ND
TOB ND
1NT8Th COL 16 0.312 16 Synergy
AMI 4 4
COL 64 0.500 4 Synergy
GEN 16 4
COL ND ND ND ND
TOB ND
1NT6Ng(CCU)/1 COL 16 0.281 32 Synergy
AMI 4 4
COL 64 0.250 8 Synergy
GEN 16 8
COL 64 0.375 8 Synergy
TOB 4 4
1NT6Th(CCU)/1 COL 8 0.062 32 Synergy
AMI 0.5 32
COL 32 0.375 8 Synergy
GEN 32 4
COL 16 0.312 16 Synergy
TOB 4 4
1NT6R(CCU) COL 32 0.250 8 Synergy
AMI 2 8
COL 32 0.187 8 Synergy
GEN 8 16
COL ND ND ND ND
TOB

CCU, Cardiac Care Unit; MIC, Minimum inhibitory concentrations; COL, Colistin; AMI, Amikacin; FICI, Fractional inhibitory concentration index; GEN, Gentamicin; TOB, Tobramycin; ND, not determined.